Pathstone Holdings’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Sell
47,236
-3,891
-8% -$1.08M 0.03% 388
2026
Q1
$15.1M Buy
51,127
+3,630
+8% +$1.08M 0.06% 223
2025
Q4
$13M Sell
47,497
-1,981
-4% -$538K 0.05% 256
2025
Q3
$13.4M Buy
49,478
+3,800
+8% +$1.03M 0.05% 254
2025
Q2
$12.6M Buy
45,678
+2,108
+5% +$573K 0.05% 256
2025
Q1
$11.6M Buy
43,570
+5,305
+14% +$1.31M 0.05% 295
2024
Q4
$8.92M Sell
38,265
-275
-0.7% -$63.2K 0.04% 353
2024
Q3
$8.5M Sell
38,540
-899
-2% -$186K 0.04% 383
2024
Q2
$7.75M Sell
39,439
-2,286
-5% -$472K 0.04% 387
2024
Q1
$8.98M Buy
41,725
+4,515
+12% +$948K 0.04% 329
2023
Q4
$7.89M Buy
+37,210
New +$7.94M 0.04% 306

Other funds holding CME

Pathstone Holdings's CME Position: Q2 2026 in Review

Pathstone Holdings reduced its CME Group (CME) stake by 7.6% in Q2 2026, selling an estimated $1.08M and leaving 47,236 shares worth $10.5M. The position accounts for 0.03% of the portfolio, ranked #388.

Pathstone Holdings first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $15.1M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Pathstone Holdings held 47,236 shares of CME Group worth $10.5M as of Q2 2026.
  • Pathstone Holdings sold 3,891 CME Group shares in Q2 2026, an estimated $1.08M.
  • CME Group made up 0.03% of Pathstone Holdings's portfolio in Q2 2026, its #388 holding.
  • Pathstone Holdings first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's CME Group position peaked at $15.1M in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.